SCOPUS 정보 검색 플랫폼

Volumn 79, Issue 1, 2000, Pages 28-32

Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look

(6) Makhija, S a Sabbatini, P a Aghajanian, C a Venkatraman, E a Spriggs, D R a Barakat, R a

a MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYTARABINE; FLOXURIDINE; MITOXANTRONE; PACLITAXEL; THIOTEPA;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; GASTROINTESTINAL TOXICITY; GYNECOLOGIC CANCER; HUMAN; NEUROPATHY; NEUROTOXICITY; OVARY CANCER; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SECOND LOOK SURGERY; TREATMENT OUTCOME;

EID: 0033769821 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2000.5890 Document Type: Article

Times cited : (7)

References (15)

1
- 0033006836
- Cancer statistics, 1999
- (1999) CA Cancer J Clin , vol.49 , pp. 8-31
- Landis, S.H.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

2
- 0030054309
- Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
- (1996) N Engl J Med , vol.334 , pp. 1-6
- McGuire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.E.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷ Davidson, M.⁸

3
- 0346423733
- Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
- (1991) N Engl J Med , vol.335 , pp. 1801-1805
- Alberts, D.S.¹ Liu, P.Y.² Hannigan, E.V.³

4
- 0001019113
- Randomized Phase III study of intravenous (IV) cisplatin (C1S)/paclitaxel (PAC) versus moderately high dose IV carboplatin followed by IV PAC and intraperitoneal CIS in optimal residual ovarian cancer
- (1998) Proc ASCO , vol.17 , pp. 1392
- Markman, M.¹ Bundy, B.² Benda, J.³

5
- 0025811837
- Intraperitoneal chemotherapy
- (1991) Semin Oncol , vol.18 , Issue.3 , pp. 248-254
- Markman, M.¹

6
- 0032940547
- Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer
- (1999) Gynecol Oncol , vol.73 , pp. 96-101
- Husain, A.¹ Sabbatini, P.² Spriggs, D.R.³ Fennelly, D.⁴ Aghajanian, C.⁵ Barakat, R.R.⁶ Curtin, J.P.⁷ Venkatraman, E.⁸ Hoskins, W.J.⁹ Markman, M.¹⁰

7
- 0032054093
- A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with stage II-IV epithelial ovarian cancer following negative surgical assessment
- (1998) Gynecol Oncol , vol.69 , pp. 17-22
- Barakat, R.R.¹ Almadrones, L.² Venkatraman, E.S.³ Aghajanian, C.⁴ Brown, C.⁵ Shapiro, F.⁶ Curtin, J.P.⁷ Spriggs, D.R.⁸

8
- 0030909491
- Pharmacokinetic problems in peritoneal drug administration: Tissue penetration and surface exposure
- (1997) J Natl Cancer Inst , vol.86 , pp. 480-487
- Dedrick, R.L.¹ Flessner, M.F.²

9
- 0032031730
- Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancer
- (1998) Gynecol Oncol , vol.68 , pp. 267-273
- Recio, F.O.¹ Piver, M.S.² Hempling, R.E.³ Driscoll, D.L.⁴

10
- 0025825680
- Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer
- (1991) J Clin Oncol , vol.9 , pp. 978-982
- Markman, M.¹ Hakes, T.² Reichman, B.³ Lewis J.L., Jr.⁴ Rubin, S.⁵ Jones, W.⁶ Almadrones, L.⁷ Hoskins, W.J.⁸

11
- 0028862180
- Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: A Gynecologic Oncology Group pilot study
- (1995) J Clin Oncol , vol.13 , pp. 2961-2967
- Francis, P.¹ Rowinsky, E.² Schneider, J.³ Hakes, T.⁴ Hoskins, W.⁵ Markman, M.⁶

12
- 0027083054
- Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer
- (1992) J Clin Oncol , vol.10 , pp. 1479-1484
- Markman, M.¹ Reichman, B.² Hakes, T.³ Lewis, J.L.⁴ Jones, W.⁵ Rubin, S.⁶ Barakat, R.⁷ Curtin, J.⁸ Almadrones, L.⁹ Hoskins, W.¹⁰

13
- 9344260298
- Intraperitoneal mitoxantrone or floxuridine: Effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy - A randomized phase II study by the Southwest Oncology Group
- (1998) Gynecol Oncol , vol.61 , pp. 395-402
- Muggia, F.M.¹ Liu, P.Y.² Alberts, D.S.³ Wallace, D.L.⁴ O'Toole, R.V.⁵ Terraria, C.Y.⁶ Franklin, E.W.⁷ Herrer, G.W.⁸ Goldberg, D.A.⁹ Hanningan, E.V.¹⁰

14
- 0027163692
- Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer
- (1993) Gynecol Oncol , vol.50 , pp. 100-104
- Markman, M.¹ Reichman, B.² Hakes, T.³ Rubin, S.⁴ Lewis J.L., Jr.⁵ Jones, W.⁶ Barakat, R.⁷ Curtin, J.P.⁸ Almadrones, L.⁹ Hoskins, W.J.¹⁰

15
- 0032408118
- A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: A Gynecologic Oncology Group study
- (1998) Gynecol Oncol , vol.71 , pp. 410-415
- Feun, L.¹ Blessing, J.² Major, F.³ DiSaia, P.⁴ Alvarez, R.⁵ Berek, J.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.